Managers’ transactions
Faron Pharmaceuticals Oy ("Faron" or the "Company") Managers' transactions Company announcement, 12 May 2020 at 8 PM (EEST) TURKU - FINLAND - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces today that Mr Toni Hänninen, Chief Financial Officer of the Company, acquired 3,500 ordinary shares in Faron at a price of €4.3255 per share on 12 May 2020. Following these purchases, Mr Hänninen holds 50,297 ordinary shares in the Company. The notification below, which has been made in accordance with